购物车
- 全部删除
- 您的购物车当前为空
Lifitegrast sodium (SAR-1118-023 sodium) 是一种小分子整合素拮抗剂,通过阻断两种重要的细胞表面蛋白(淋巴细胞功能相关抗原 1 和细胞间粘附分子 1)的结合来抑制 T 细胞介导的炎症,可减少眼表炎症,可用于研究干眼症。
Lifitegrast sodium (SAR-1118-023 sodium) 是一种小分子整合素拮抗剂,通过阻断两种重要的细胞表面蛋白(淋巴细胞功能相关抗原 1 和细胞间粘附分子 1)的结合来抑制 T 细胞介导的炎症,可减少眼表炎症,可用于研究干眼症。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 243 | 现货 | |
5 mg | 询价 | 现货 | |
10 mg | 询价 | 现货 |
产品描述 | Lifitegrast sodium (SAR-1118-023 sodium) is a small molecule integrin antagonist that inhibits T cell-mediated inflammation by blocking the binding of two important cell surface proteins (lymphocyte function-associated antigen 1 and intercellular adhesion molecule 1), which reduces inflammation of the ocular surface, and may be used in the study of dry eye. |
别名 | SHP-606 sodium, 立他司特钠盐, SAR1118-023 sodium, SAR 1118-023 sodium, SAR-1118-023 sodium, Xiidra sodium |
分子量 | 637.46 |
分子式 | C29H23Cl2N2NaO7S |
CAS No. | 1119276-80-0 |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | H2O: 80 mg/mL (125.50 mM), Sonication is recommended. DMSO: 80 mg/mL (125.50 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
H2O/DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.